CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

for the period ended 31 March 2020

  Download (EXCEL)

 

 

  2020
R’m
  Change
%
2019
R’m
 
Cash generated from operations  2 376     (8.3) 2 591    
Transaction costs paid  (5)      (30)   
Interest received       13    
Tax paid  (382)      (477)   
Net cash from operating activities  1 997     (4.8) 2 097    
Capital expenditure  (1 145)      (925)   
Investments (net of cash acquired) and contingent considerations paid  (1)      (236)   
Other  (81)      (97)   
Net cash utilised in investing activities  (1 227)      (1 258)   
Proceeds from interest-bearing borrowings  7 631       2 076    
Repayment of interest-bearing borrowings  (8 009)      (2 610)   
Dividends paid to Company's shareholders  (778)      (734)   
Finance cost paid  (340)      (467)   
Other  (158)      (153)   
Net cash utilised in financing activities  (1 654)      (1 888)   
Net decrease in cash and cash equivalents  (884)      (1 049)   
Cash and cash equivalents – beginning of the period  677       1 006    
Effect of foreign currency rate movements  139       24    
Cash and cash equivalents at the end of the period1  (68)      (19)   
1 Cash and cash equivalents at the end of the period are net of bank overdrafts.

Connect with us


© Copyright by Life Healthcare group. All rights reserved.